Streetbeat News

Price Targets

GRPN

Goldman Sachs analyst Eric Sheridan has maintained a Sell rating on Groupon (NASDAQ:GRPN) but increased the price target from $5 to $7.5.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:38 pm

EXPE

Goldman Sachs analyst Eric Sheridan has reaffirmed a Buy rating on Expedia Group (NASDAQ:EXPE) and increased the price target from $155 to $190.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:37 pm

SMCI

Wedbush analyst Matt Bryson reiterated a Neutral rating on Super Micro Computer (NASDAQ:SMCI) and maintained a $250 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:36 pm

AMZN

Wedbush analyst Scott Devitt has reiterated an Outperform rating on Amazon.com (NASDAQ:AMZN) and maintained a price target of $210.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:33 pm

DFS

Goldman Sachs analyst Ryan Nash has maintained a Buy rating on Discover Financial Services (NYSE:DFS) but has reduced the price target from $139 to $121.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:32 pm

BKNG

Goldman Sachs analyst Eric Sheridan has maintained a Neutral rating on Booking Holdings (NASDAQ:BKNG) and increased the price target from $3080 to $3610.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:31 pm

ANGI

Goldman Sachs analyst Eric Sheridan has reaffirmed a Buy rating on Angi (NASDAQ:ANGI) but reduced the price target from $4.5 to $3.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:29 pm

IKNA

Wedbush analyst David Nierengarten has reiterated an Outperform rating on Ikena Oncology (NASDAQ:IKNA) and maintained a price target of $8. The reaffirmation of the positive outlook and price target suggests confidence in the company's prospects.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:29 pm

TCBI

Wedbush analyst David Chiaverini has maintained a Neutral rating on Texas Capital Bancshares (NASDAQ:TCBI) and reduced the price target from $70 to $68.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:27 pm

ISRG

Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on Intuitive Surgical (NASDAQ:ISRG) and increased the price target from $363 to $416.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 1:24 pm